Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis

Detalhes bibliográficos
Autor(a) principal: Eleotério,Renato Barros
Data de Publicação: 2012
Outros Autores: Borges,Andréa Pacheco Batista, Pontes,Kelly Cristine de Sousa, Fernandes,Natália Alves, Soares,Priscila Ferreira, Silva,Mariana Brettas, Martins,Naira Jandafet Sampaio, Machado,João Paulo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Ceres
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003
Resumo: Among the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments.
id UFV-5_c6b979aff50702fbd71a57b9309121fc
oai_identifier_str oai:scielo:S0034-737X2012000500003
network_acronym_str UFV-5
network_name_str Revista Ceres
repository_id_str
spelling Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysisdegenerative joint diseaseosteoarthritisarthrosischondroprotectivenutraceuticalAmong the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments.Universidade Federal de Viçosa2012-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003Revista Ceres v.59 n.5 2012reponame:Revista Ceresinstname:Universidade Federal de Viçosa (UFV)instacron:UFV10.1590/S0034-737X2012000500003info:eu-repo/semantics/openAccessEleotério,Renato BarrosBorges,Andréa Pacheco BatistaPontes,Kelly Cristine de SousaFernandes,Natália AlvesSoares,Priscila FerreiraSilva,Mariana BrettasMartins,Naira Jandafet SampaioMachado,João Pauloeng2015-04-07T00:00:00ZRevista
dc.title.none.fl_str_mv Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
title Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
spellingShingle Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
Eleotério,Renato Barros
degenerative joint disease
osteoarthritis
arthrosis
chondroprotective
nutraceutical
title_short Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
title_full Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
title_fullStr Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
title_full_unstemmed Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
title_sort Glucosamine and chondroitin sulfate in the repair of osteochondral defects in dogs - clinical-radiographic analysis
author Eleotério,Renato Barros
author_facet Eleotério,Renato Barros
Borges,Andréa Pacheco Batista
Pontes,Kelly Cristine de Sousa
Fernandes,Natália Alves
Soares,Priscila Ferreira
Silva,Mariana Brettas
Martins,Naira Jandafet Sampaio
Machado,João Paulo
author_role author
author2 Borges,Andréa Pacheco Batista
Pontes,Kelly Cristine de Sousa
Fernandes,Natália Alves
Soares,Priscila Ferreira
Silva,Mariana Brettas
Martins,Naira Jandafet Sampaio
Machado,João Paulo
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Eleotério,Renato Barros
Borges,Andréa Pacheco Batista
Pontes,Kelly Cristine de Sousa
Fernandes,Natália Alves
Soares,Priscila Ferreira
Silva,Mariana Brettas
Martins,Naira Jandafet Sampaio
Machado,João Paulo
dc.subject.por.fl_str_mv degenerative joint disease
osteoarthritis
arthrosis
chondroprotective
nutraceutical
topic degenerative joint disease
osteoarthritis
arthrosis
chondroprotective
nutraceutical
dc.description.none.fl_txt_mv Among the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments.
description Among the proposed treatments to repair lesions of degenerative joint disease (DJD), chondroprotective nutraceuticals composed by glucosamine and chondroitin sulfate are a non-invasive theraphy with properties that favors the health of the cartilage. Although used in human, it is also available for veterinary use with administration in the form of nutritional supplement independent of prescription, since they have registry only in the Inspection Service, which does not require safety and efficacy testing. The lack of such tests to prove efficacy and safety of veterinary medicines required by the Ministry of Agriculture and the lack of scientific studies proving its benefits raises doubts about the efficiency of the concentrations of such active substances. In this context, the objective of this study was to evaluate the efficacy of a veterinary chondroprotective nutraceutical based on chondroitin sulfate and glucosamine in the repair of osteochondral defects in lateral femoral condyle of 48 dogs, through clinical and radiographic analysis. The animals were divided into treatment group (TG) and control group (CG), so that only the TG received the nutraceutical every 24 hours at the rate recommended by the manufacturer. The results of the four treatment times (15, 30, 60 and 90 days) showed that the chondroprotective nutraceutical, in the rate, formulation and administration at the times used, did not improve clinical signs and radiologically did not influence in the repair process of the defects, since the treated and control groups showed similar radiographic findings at the end of the treatments.
publishDate 2012
dc.date.none.fl_str_mv 2012-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-737X2012000500003
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0034-737X2012000500003
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Universidade Federal de Viçosa
publisher.none.fl_str_mv Universidade Federal de Viçosa
dc.source.none.fl_str_mv Revista Ceres v.59 n.5 2012
reponame:Revista Ceres
instname:Universidade Federal de Viçosa (UFV)
instacron:UFV
instname_str Universidade Federal de Viçosa (UFV)
instacron_str UFV
institution UFV
reponame_str Revista Ceres
collection Revista Ceres
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1728006780363997184